A limited role of iNKT cells in controlling systemic Candida albicans infections

Japanese Journal of Infectious Diseases

Volumn 65, Issue 6, 2012, Pages 522-526

  Tarumoto, Norihito ^a,b   Kinjo, Yuki ^a   Ueno, Keigo ^a   Okawara, Akiko ^a   Watarai, Hiroshi ^c,d   Taniguchi, Masaru ^c   Maesaki, Shigefumi ^b   Miyazaki, Yoshitsugu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; INFECTION CONTROL; INVARIANT NATURAL KILLER T CELL; KIDNEY; LIVER; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGEN CLEARANCE; PLASMA; SPLEEN; SURVIVAL;

ANIMAL STRUCTURES; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; SURVIVAL ANALYSIS;

EID: 84869759781     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.65.522     Document Type: Article

References (37)

1. Vonk, A.G., Netea, M.G., van der Meer, J.W., et al. (2006): Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Expert. Opin. Biol. Ther., 6, 891-903.
2. Pfaller, M.A., Diekema, D.J., Jones, R.N., et al. (2002): Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbiol., 40, 852-856.
3. Wisplinghoff, H., Bischoff, T., Tallent, S.M., et al. (2004): Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis., 39, 309-317.
4. Horn, D.L., Neofytos, D., Anaissie, E.J., et al. (2009): Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis., 48, 1695-1703.
5. Pfaller, M.A. and Diekema D.J. (2007): Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev., 20, 133-163.
6. Netea, M.G., Brown, G.D., Kullberg, B.J., et al. (2008): An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol., 6, 67-78.
7. Kullberg, B.J., van 't Wout, J.W., Hoogstraten, C., et al. (1993): Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis., 168, 436-443.
8. Djeu, J.Y., Blanchard, D.K., Halkias, D., et al. (1986): Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J. Immunol., 137, 2980-2984.
9. Marodi, L., Schreiber, S., Anderson, D.C., et al. (1993): Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest., 91, 2596-2601.
10. Balish, E., Wagner, R.D., Vazquez-Torres, A., et al. (1998): Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J. Infect. Dis., 178, 478-487.
11. Cenci, E., Mencacci, A., Del Sero, G., et al. (1998): IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol., 161, 3543-3550.
12. Kaposzta, R., Tree, P., Marodi, L., et al. (1998): Characteristics of invasive candidiasis in gamma interferon-and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun., 66, 1708-1717.
13. Jones-Carson, J., Vazquez-Torres, A., van der Heyde, H.C., et al. (1995): Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med., 1, 552-557.
14. Tupin, E., Kinjo, Y. and Kronenberg, M. (2007): The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol., 5, 405-417.
15. Taniguchi, M., Tashiro, T., Dashtsoodol, N., et al. (2010): The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. Int. Immunol., 22, 1-6.
16. Godfrey, D.I., Pellicci, D.G., Patel, O., et al. (2010): Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol., 22, 61-67.
17. Kinjo, Y. and Ueno, K. (2011): iNKT cells in microbial immunity: recognition of microbial glycolipids. Microbiol. Immunol., 55, 472-482.
18. Cohen, N.R., Tatituri, R.V., Rivera, A., et al. (2011): Innate recognition of cell wall beta-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe, 10, 437-450.
19. Kawakami, K., Kinjo, Y., Uezu, K., et al. (2001): Monocyte chemoattractant protein-1-dependent increase of Va14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol., 167, 6525-6532.
20. Cui, J., Shin, T., Kawano, T., et al. (1997): Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science, 278, 1623-1626.
21. Dieli, F., Taniguchi, M., Kronenberg, M., et al. (2003): An antiinflammatory role for Va14 NK T cells in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. J. Immunol., 171, 1961-1968.
22. Kawakami, K., Kinjo, Y., Uezu, K., et al. (2002):Minimal contribution of Va14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol., 46, 207-210.
23. MacCallum, D.M. (2009): Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res., 9, 1111-1122.
24. Geissmann, F., Cameron, T.O., Sidobre, S., et al. (2005): Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol., 3, e113.
25. Lee, W.Y., Moriarty, T.J., Wong, C.H.Y., et al. (2010): An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat. Immunol., 11, 295-302.
26. Barral, P., Sanchez-Nino, M.D., van Rooijen, N., et al. (2012): The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. doi: 10.1038/emboj.2012.87.
27. Romani, L., Mencacci, A., Cenci, E., et al. (1993): Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect. Immun., 61, 3769-3774.
28. Renna, M.S., Figueredo, C.M., Rodriguez-Galan, M.C., et al. (2012): Abrogation of spontaneous liver tolerance during immune response to Candida albicans: contribution of NKT and hepatic mononuclear cells. Int. Immunol., 24, 315-325.
29. Ishigami, M., Nishimura, H., Naiki, Y., et al. (1999): The roles of intrahepatic Va14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice. Hepatology, 29, 1799-1808.
30. Berntman, E., Rolf, J., Johansson, C., et al. (2005): The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur. J. Immunol., 35, 2100-2109.
31. Brigl, M., Bry, L., Kent, S.C., et al. (2003): Mechanism of CD1drestricted natural killer T cell activation during microbial infection. Nat. Immunol., 4, 1230-1237.
32. Greenfield, R.A., Abrams, V.L., Crawford, D.L., et al. (1993): Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. Infect. Immun., 61, 2520-2525.
33. Arancia, G., Stringaro, A., Crateri, P., et al. (1998): Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicans. Cell. Immunol., 186, 28-38.
34. Conti, H.R., Shen, F., Nayyar, N., et al. (2009): Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med., 206, 299-311.
35. Michel, M.L., Mendes-da-Cruz, D., Keller, A.C., et al. (2008): Critical role of ROR-gt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA, 105, 19845-19850.
36. Coquet, J.M., Chakravarti, S., Kyparissoudis, K., et al. (2008): Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc. Natl. Acad. Sci. USA, 105, 11287-11292.
37. Watarai, H., Sekine-Kondo, E., Shigeura, T., et al. (2012): Development and function of invariant natural killer T cells producing T(h)2-and T(h)17-cytokines. PLoS Biol., 10, e1001255.